MyMD Pharmaceuticals Inc (MYMD)

[BioFan1]

In the meantime, buying the dips is proving to be a great strategy. This little gem has $50+ possibility. There is a reason top scientists at Hopkins are all over this. Three peer-reviewed animal studies in prestigious journals, all with positive results. Potential to treat multiple diseases. No adverse side effects demonstrated in Phase I human trial. If you are reading this, consider yourself to be one of the lucky ones with the opportunity to get in before Phase II results are out later this year.